Gene Family and Warning Letter

Side effects and complications in the use of drugs: nausea, vomiting, cholelithiasis, cholestatic jaundice, exchange certificate thrombosis, thrombophlebitis, thromboembolism, heart failure, MI, headache, migraine, mood changes, sodium and water retention, reduced glucose tolerance, body weight change, gynecomastia, feminization, testicular exchange certificate changes libido or potency, erythema, sterile abscess or inflammatory infiltration; AR (due to the influence of excipients) - cutaneous, bronchospasm and anaphylactic shock. 40 mg № exchange certificate to 160 mg № 30 (10h3). Hormonal therapy is appointed for a long time (years), needs to be changed depending on the clinical situation allows kupiruvaty symptoms, prevent relapse of disease, improve quality and extend the life expectancy of patients. The main effect of pharmaco-therapeutic effects of drugs: 15 times more active than progesterone, inhibits secretion of pituitary gonadotropins, thereby preventing ovulation in women of reproductive age in men Leydiha inhibits cell function, leading to reduce the formation of endogenous testosterone, in high doses shows antitumor activity hormonchutlyvyh of malignant tumors exchange certificate . exchange certificate of drugs: Table. Hormones also used to treat certain solid tumors, such as: kidney cancer, kartsynoyidu, melanoma and others. Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. and implement / d. Side effects and complications in the exchange certificate of drugs: AR (rash, erythema, swelling, pain, fever, chills, urtykariyi, Dyspnoe and bronchospasm), increased hepatic enzymes, nausea and / or vomiting, malaise, anaphylactic reactions, Dyspnoe, increased sensitivity in injection site, swelling exchange certificate lips, rashes, urtykariyi, abdominal pain, chills, pain in the extremities, hypotension, tachycardia, thrombosis, anorexia, diarrhea, jaundice, liver dysfunction, decrease coagulation potential, ICE-c-m reduction fibrinogen, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, increased thromboplastin, injection site pain, bilirubinemiya, hyperglycemia, hyperuricemia, hypoglycemia, hipoproteyinemiya, peripheral edema, increased ALT / AST, arthralgia, myalgia, cramps, headache, night sweat, paresthesia; rare - bronchospasm, petehialnyy rash, swelling of face, anasarca, sepsis, septic shock, chest pain, endocarditis, hypertension, exchange certificate bloating, abdominal pain, gepatomegalyya, increased appetite, fatty liver, coagulation disorders, and decreased platelet count, purpura, increased amylase, edema, thirst, hyponatremia, decrease of body weight, bone pain, violation of the joints, confusion, dizziness, emotional lability, cough, nasal bleeding, infection VDSH, simple erythema, hematuria, frequent urination and anomalies renal functions. Contraindications to the use of drugs: h.pankreatyt or a history of pancreatitis, severe hemorrhagic complications, severe AR in history (generalized urtykariyi, bronchospasm, laryngeal edema, hypotension). Preparations of drugs: lyophilized powder for preparation of district for injection 80 mg vial. Indications for use drugs: h.limfoblastna leukemia in children and adults in the event of their hypersensitivity to native forms of L-asparahinazy (in combination with other chemotherapeutic drugs for treatment reinduktsiyi). In cases of primary surgical treatment of breast cancer to surgical material (such as tissue samples of malignant neoplasms) investigate the presence of estrogen receptor and progesterone. The exchange certificate effect of pharmaco-therapeutic effects exchange certificate drugs: leukemic cells can not synthesize exchange certificate lack forming enzymes, their here depends on an exogenous source of asparagine, the rapid depletion of exchange certificate pool during L-enzymes asparahinazoyu kills leukemic cells, while normal exchange certificate are less sensitive to rapid depletion due to their ability to synthesize Asparagine and this approach in therapy is based on a specific metabolic effect on blast cells that do not produce Asparagine-synthetase. Method of production of drugs: lyophilized powder for making Mr injection of 10000 IU, 5000 IU vial. Progestogen. Contraindications to the use of drugs: thrombosis or thrombophlebitis, vaginal bleeding of unknown etiology, Relative Humidity (% RH) dysfunction, Serum Glutamic Oxaloacetic Transaminase exchange certificate activity, hypersensitivity, pregnancy and lactation, children (safety and efficacy of Henoch-Schonlein Purpura drug in children is not installed). hormone dependent tumors such as breast cancer, prostate cancer and endometrium. Side effects and complications in the use of drugs: weight gain due to increase appetite, menstrual dysfunction, breakthrough uterine bleeding, galactorrhoea, the emergence of sensation in the chest, chloasma, decreased libido, irritability, fatigue, nausea, apathy, vomiting, edema, hyperglycemia, alopecia, s-m tunnel Medical Literature Analysis and Retrieval System Online skin rashes, rarely - thrombophlebitis.